Clinical Trial

SBRT for Hepatocellular Carcinoma Patients With Partial Response to TACE

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a pilot study where patients with Hepatocellular Carcinoma (HCC) that have failed Transarterial Chemoembolization (TACE) will be treated with Stereotactic Body Radiation Therapy (SBRT). The focus of the study will be to evaluate safety and efficacy in our population of patients.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2014-08-19; most recent amendment 2024-12-04.
Status change: Recruiting → Active, Not Recruiting 2020-01-10
Trial Details
NCT Number NCT02221778
Lead Sponsor University of Sao Paulo
Conditions Carcinoma, Hepatocellular
Enrollment 25 participants
Start Date 2014-08
Primary Completion 2024-12 (estimated)
Study Completion 2024-12 (estimated)
Updated on ClinicalTrials.gov 2024-12-06